Home > PS Ratio > GLENMARK LIFE SCIENCES

GLENMARK LIFE SCIENCES
PS (Price/Sales) Ratio

The Current P/S Ratio of GLENMARK LIFE SCIENCES is 6.14.

Share Price ₹1,149.6Sep 06,2024
Market Cap ₹14,082.0 Cr
Sales-TTM₹2,293.4 CrTTM-Standalone Results
Price/Sales6.14xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for GLENMARK LIFE SCIENCES
Please provide your vote to see the results
GLENMARK LIFE SCIENCES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best 1M Momentum Small Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of GLENMARK LIFE SCIENCES

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of GLENMARK LIFE SCIENCES is calculated as :

Current Market Cap [ ₹14,082.0 Cr] as on Sep 06,2024

(/) Sales [ ₹2,293.4 Cr] based on TTM-Standalone Results

(=) P/S Ratio [ 6.14x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for GLENMARK LIFE SCIENCES , the investors are currently willing to pay '6.14 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of GLENMARK LIFE SCIENCES !

The chart below summarizes the trend in P/S Ratio of GLENMARK LIFE SCIENCES over the last five years.

Historical PS (Price/Sales) ratio chart of GLENMARK LIFE SCIENCES


PS Ratio Performance Analysis for GLENMARK LIFE SCIENCES

- GLENMARK LIFE SCIENCES 's latest p/e ratio is 6.14x.

- GLENMARK LIFE SCIENCES 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 1.81x.

- GLENMARK LIFE SCIENCES 's operated at median p/e ratio of 2.22x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, GLENMARK LIFE SCIENCES 's p/e ratio peaked in Mar2024 at 4.16x.

- GLENMARK LIFE SCIENCES 's p/e ratio hit its five-year low in Mar2021 of 0x.


How does GLENMARK LIFE SCIENCES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
GLENMARK LIFE SCIENCES 2,293.46.1414,082.0
SUN PHARMACEUTICAL INDUSTRIES LTD49,208.88.89437,483.0
CIPLA LTD26,139.14.98130,171.0
DR REDDYS LABORATORIES LTD28,949.33.84111,298.0
ZYDUS LIFESCIENCES LTD20,615.35.37110,736.0
DIVIS LABORATORIES LTD8,185.016.67136,472.0
MANKIND PHARMA LTD10,649.69.1297,120.1
TORRENT PHARMACEUTICALS LTD10,996.010.52115,647.0
LUPIN LTD20,797.14.95102,962.0
AUROBINDO PHARMA LTD29,718.43.0390,146.6
ABBOTT INDIA LTD5,927.510.7463,637.2

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs GLENMARK LIFE SCIENCES 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 3.03x
Max industry PS 16.67x
Median industry PS 6.14x
Average industry PS 7.66x



You may also like the below Video Courses